Hydroxychloroquine Market Anticipated to Reach Valuation of USD 2,598.6 Million by 2028
In terms of revenue, the Hydroxychloroquine Market is expected to reach USD 2,598.6 Million by 2028, growing at a Compound Annual Growth Rate (CAGR) of 5.7% from 2022 to 2028. The has an ability to speed up recovery processes in the treatment of patients suffering from diseases like malaria & rheumatoid arthritis. This has contributed in growing demand for the product globally. With this regard, the increasing product demand has motivated several companies for enhancing their production methods and capabilities associated with the product.
- Tablet sub-segment in type segment is projected to have the fastest growth during the forecast period because of the easy availability of the product in tablet form which is about to grow at a higher Compound Annual Growth Rate (CAGR). Additionally, higher demand for tablets due to their ease of consumption and cost-effectiveness driving the Hydroxychloroquine Market growth.
- Online pharmacy in the distribution channel segment has held a higher market share in 2021. The growth in the segment is driven by the continuous expansion of the e-commerce sector coupled with the limited availability of medicine in hospital pharmacies & retail pharmacies and its time-saving feature.
Some of key players in Hydroxychloroquine Market include - Sanofi, Amneal Pharmaceuticals, Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Novartis AG, Zydus Cadila, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Lupin Limited, Prasco Laboratories.
It was seen that has shown positive signs in the recovery phase of patients suffering from coronavirus. As a result, there was a sudden hike in the demand for products across the world. Countries like the United States are putting efforts and investment in the development of an efficient treatment option with the help of is one of the factors that drive the market growth. The increasing cases of malaria are creating growth opportunities for the companies that are operating in this market. Thus, the growing demand for products all over the globe is having a positive impact on the growth of the overall market.
North America is holding a dominant position in the regional segment. High production of in various countries across the region is contributing in the growth of the market. India at present time is the largest producer of . The high potential of this drug in treating COVID-19 had enforced India to impose a ban on the export of the drug, which has led to tension in U.S.–India relations.
The Hydroxychloroquine is segmented as follows:
Browse market data Tables and Figures
Pages and in-depth TOC on "Hydroxychloroquine Market by Application (Coronavirus Disease (COVID-19), Malaria, Lupus Erythematosus, Rheumatoid Arthritis), by Distribution Channel (Online Pharmacy, Hospital Pharmacy, Retail Pharmacy), by Region (North America, Latin America, Europe, Asia Pacifc) - Global Industry Assessment (2016 - 2021) & Forecast (2022 - 2028)"
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- GCC Countries
- South Africa
- Rest of MEA
Vantage Market Research is a reputed company committed to providing high quality data and market research services. The company provides quantified B2B high quality research on more than 20,000 emerging markets. The company offers detailed reports on multiple industries including chemical materials and energy, food and beverages, healthcare, technology, etc. The company comprises over 125 analysts and consultants, adding more than 1,100 market research reports to its vast database every year. The company’s clientele base spans across 70% of the Global Fortune 500 companies.